Biohaven (BHVN) Total Current Liabilities (2021 - 2026)

Biohaven (BHVN) reported Total Current Liabilities of $52.1 million for Q1 2026, down 68.25% on a YoY basis from $164.0 million in Q1 2025, and down 55.08% sequentially from $115.9 million in Q4 2025.

Biohaven (BHVN) Total Current Liabilities (2021 - 2026) Analysis & Trends

Biohaven (BHVN) has 6 years of Total Current Liabilities data on file, last reported at $52.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 68.25% year-over-year to $52.1 million; the trailing twelve-month figure through Mar 2026 stood at $52.1 million (down 68.25% YoY), and the FY2025 full-year result was $115.9 million, down 24.83% from the prior year.
  • Total Current Liabilities eased to $52.1 million in Q1 2026, from $115.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $164.0 million in Q1 2025 to a low of $28.4 million in Q3 2022.
  • A 5-year average of $103.8 million and a median of $113.0 million in 2025 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities surged 178.27% in 2024 and slumped 68.25% in 2026, its largest moves.
  • Tracing BHVN's Total Current Liabilities over 5 years: stood at $90.0 million in 2022, then sank by 38.43% to $55.4 million in 2023, then surged by 178.27% to $154.2 million in 2024, then retreated by 24.83% to $115.9 million in 2025, then slumped by 55.08% to $52.1 million in 2026.
  • Business Quant data shows BHVN's Total Current Liabilities at $52.1 million in Q1 2026, $115.9 million in Q4 2025, and $113.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Biohaven 2.16 Bn 1.81 Bn - 52.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 52.08 Mn
Dec 31, 2025 115.93 Mn
Sep 30, 2025 113.02 Mn
Jun 30, 2025 124.32 Mn
Mar 31, 2025 164.03 Mn
Dec 31, 2024 154.23 Mn
Sep 30, 2024 152.29 Mn
Jun 30, 2024 156.21 Mn
Mar 31, 2024 86.59 Mn
Dec 31, 2023 55.42 Mn
Sep 30, 2023 62.18 Mn
Jun 30, 2023 87.85 Mn
Mar 31, 2023 114.01 Mn
Dec 31, 2022 90.02 Mn
Sep 30, 2022 28.44 Mn
Dec 31, 2021 41.94 Mn